IRF8 and metabolic bone disorder: IRF8 acts as a negative regulator in osteoclast differentiation and maturation.200 The absence of IRF8 leads to an increase in osteoclasts, contributing to bone metabolic disorders and playing a pivotal role in osteoclast-related inflammatory diseases such as multiple root resorption.201–204